title: The diuretic- and Bartter-like salt-losing tubulopathies.
authors.affiliation: Department of Pediatrics, Philipps University, Marburg, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Jeck
authors.forename: M
authors.initials: M
authors.lastname: Konrad
authors.forename: M
authors.initials: M
authors.lastname: Hess
authors.forename: H W
authors.initials: HW
authors.lastname: Seyberth
mesh_terms: D027321:Anion Transport Proteins; D001477:Bartter Syndrome / Q000378:metabolism*; D001581:Benzothiadiazines; D018118:Chloride Channels / Q000235:genetics; D004232:Diuretics / Q000009:adverse effects*; D005665:Furosemide / Q000009:adverse effects; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007231:Infant, Newborn; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism*; D007684:Kidney Tubules; D008565:Membrane Proteins; D009154:Mutation / Q000502:physiology; D015221:Potassium Channels / Q000235:genetics; D024661:Potassium Channels, Inwardly Rectifying; D012965:Sodium Chloride / Q000378:metabolism*; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects
chemical_list: D027321:Anion Transport Proteins; D001581:Benzothiadiazines; C412733:CLCNKB protein, human; D018118:Chloride Channels; D004232:Diuretics; C086989:KCNJ1 protein, human; D008565:Membrane Proteins; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D049993:Sodium Chloride Symporter Inhibitors; D012965:Sodium Chloride; D005665:Furosemide